1. Corrigendum to: Pharmacologically-induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset. Issue 9 (17th November 2020) Authors: Feng, Zhihua; Ling, Karen K Y; Zhao, Xin; Zhou, Chunyi; Karp, Gary; Welch, Ellen M; Naryshkin, Nikolai; Ratni, Hasane; Chen, Karen S; Metzger, Friedrich; Paushkin, Sergey; Weetall, Marla; Ko, Chien-Ping Journal: Human molecular genetics Issue: Volume 30:Issue 9(2021) Page Start: 843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SMN protein is required throughout life to prevent spinal muscular atrophy disease progression. Issue 1 (9th August 2021) Authors: Zhao, Xin; Feng, Zhihua; Risher, Nicole; Mollin, Anna; Sheedy, Josephine; Ling, Karen K Y; Narasimhan, Jana; Dakka, Amal; Baird, John D; Ratni, Hasane; Lutz, Catherine; Chen, Karen S; Naryshkin, Nikolai A; Ko, Chien-Ping; Welch, Ellen; Metzger, Friedrich; Weetall, Marla Journal: Human molecular genetics Issue: Volume 31:Issue 1(2022) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Spinal muscular atrophy : disease mechanisms and therapy /: disease mechanisms and therapy. ([2017]) Editors: Sumner, Charlotte J; Paushkin, Sergey; Ko, Chien-Ping Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗